Dose Optimization of Pembrolizumab: Less May Be More.
Saved in:
| Title: | Dose Optimization of Pembrolizumab: Less May Be More. |
|---|---|
| Authors: | Ratain MJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Goldstein DA; Tel Aviv University, Tel Aviv, Israel.; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.; Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 May; Vol. 111 (5), pp. 993. Date of Electronic Publication: 2021 Dec 01. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.2490 |
